CAR T Cell Killing Requires the IFNγR Pathway in Solid but Not Liquid Tumours

To systematically identify potential resistance pathways in an unbiased manner, scientists conducted a genome-wide CRISPR knockout screen in glioblastoma, a disease in which CAR T cells have had limited efficacy.